Cytokine Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Cytokine General Information
Description
Developer of a membrane-based drug designed to treat osteoarthritis symptoms. The company offers a drug candidate that uses preserved bioactive compounds from human amniotic membrane, manufactured under GMP, with anti-inflammatory and regenerative properties to treat symptoms of osteoarthritis by reducing pain and improving joint function, enabling healthcare providers and patients in orthopedics to access a treatment that may delay joint replacement and reduce reliance on pain medications.
Contact Information
Website
www.cytokinebio.comCorporate Office
- Dr. Slabihoudka 6232/11
- Ostrava, 708 52
- Czech Republic
Corporate Office
- Dr. Slabihoudka 6232/11
- Ostrava, 708 52
- Czech Republic
Cytokine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 27-Oct-2026 | Completed | Out of Business | |||
| 1. Early Stage VC (Series A) | 29-Apr-2020 | Completed | Clinical Trials - General |
Cytokine Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cytokine FAQs
-
When was Cytokine founded?
Cytokine was founded in 2018.
-
Where is Cytokine headquartered?
Cytokine is headquartered in Ostrava, Czech Republic.
-
What industry is Cytokine in?
Cytokine’s primary industry is Drug Discovery.
-
Is Cytokine a private or public company?
Cytokine is a Private company.
-
What is Cytokine’s current revenue?
The current revenue for Cytokine is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
